ACP-104 in Acutely Psychotic Subjects With Schizophrenia
Clinical trial NCT00490516 · COMPLETED
Trial details
- NCT number
- NCT00490516
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2008-02-01
- Enrollment
- 247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.